Repligen (RGEN) Tops Q3 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $142.40 +2.45%
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CRMT, More
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.46, $0.04 better than the analyst estimate of $0.42. Revenue for the quarter came in at $189 million versus the consensus estimate of $181.78 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.65-$1.68, versus the consensus of $1.69. Repligen sees FY2025 revenue of $729-737 million, versus the consensus of $727.8 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
- Raymond James Upgrades Aecon Group (ARE:CN) (AEGXF) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
